SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-013339
Filing Date
2023-05-09
Accepted
2023-05-09 17:12:39
Documents
13
Period of Report
2023-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20230509_8k.htm   iXBRL 8-K 24538
  Complete submission text file 0001437749-23-013339.txt   156428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA plse-20230509.xsd EX-101.SCH 3600
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20230509_def.xml EX-101.DEF 11531
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20230509_lab.xml EX-101.LAB 15413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20230509_pre.xml EX-101.PRE 11687
7 EXTRACTED XBRL INSTANCE DOCUMENT plse20230509_8k_htm.xml XML 2557
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 23903334
SIC: 3841 Surgical & Medical Instruments & Apparatus